Nutrison 800 Complete Multi Fibre

For the dietary management of:

• Disease-related malnutrition.
• Patients with reduced energy requirements (e.g. patients who are immobile and/or have a severe neurological disorder).

• Not for parenteral use.
• Not suitable for patients requiring a fibre free diet.
• Not suitable for patients with galactosaemia.
• Not suitable for patients with cow’s milk protein allergy.
• Not suitable for infants and children under 6 years of age.
• Use with caution in children aged 6-12 years of age.
• Use with caution in individuals with a seafood allergy.
• Weight loss and protein intake must be monitored.
• Monitor hydration status.
• Must be used under medical supervision.

• Check appearance before use and shake well.
• Use at room temperature.
• Handle aseptically to ensure product remains sterile.
• Usage to be determined by a healthcare professional.
• Do not dilute or add medications to the formula.

• Store in a cool, dry place.
• Once opened, close the bottle and store in the refrigerator.
• Discard unused content after 24 hours.

Contact Nutricia Customer Experience 1800 889 480

Full ingredients list and nutritional information is available on the product fact sheet.

• Contains: milk, soy and fish.
• Halal certified.
• Nutricia UK and/or Ireland have Kosher approval for this product.
• No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
• Low lactose (lactose < 2g/100g).

1. Dickerson RN et al. Measured energy expenditure of tube-fed patients with severe neurodevelopmental disabilities. J Am Coll Nutr. 1999 Feb;18(1):61-8.
2. Dickerson RN et al. Energy requirements of non-ambulatory, tube-fed adult patients with cerebral palsy and chronic hypothermia. Nutrition. 2003 Sep;19(9):741-6.
3. Dickerson RN et al. Validation of a new method for estimating resting energy expenditure of non-ambulatory tube-fed patients with severe neurodevelopmental disabilities. Nutrition. 2002 Jul-Aug;18(7-8):578-82.
4. Beckers EJ, Jeukendrup AE et al.  Gastric emptying of carbohydrate–medium chain triglyceride suspensions at rest.  Int J Sports Med. 1992 Nov;13(8):581-4.
5. Hunt JN, Knox MT. A relationbetween the chain length of fatty acids and the slowing of gastric emptying.  J Physiol.1968 Feb;194(2):327-36.
6. Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
7. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
8. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
9. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
10. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutritionformulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
11. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
12. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model.  Abstract presented at 34th ESPEN Congress.  Sept 8-11; Barcelona, Spain.  Clinical Nutrition Supplements.  2012;7:PP239(119).
13. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
14. Cooper DA, Eldridge AL, Peters JC.  Dietary carotenoids and certain cancer, heart disease and age-related macular degeneration: A review of recent research.  Nutrition Reviews 1999; 57:201-214.

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5

# MF6 is a unique, patented blend of six soluble and insoluble fibres (soy polysaccharide, cellulose, resistant starch, gum arabic, oligofructose and inulin) reflecting the proportions of the different fibre types in a healthy diet.